Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gale

Showing results (21-30 of 338) with videos related to

Pageof 34
Sort By:
Diabetologia|December 20, 2005
Troglitazone: the lesson that nobody learned?Edwin A M Gale
Lancet (London, England)|August 18, 2009
Insulin glargine and cancer: another side to the story?Edwin A M Gale
Diabetologia|July 22, 2008
Congenital rubella: citation virus or viral cause of type 1 diabetes?E A M Gale
Heart (British Cardiac Society)|January 15, 2013
Can NICE prevent diabetes?Edwin A M Gale
Diabetes Care|November 23, 2013
Response to comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125Edwin A M Gale
Diabetes|April 21, 2012
GLP-1-based therapies and the exocrine pancreas: more light, or just more heat?Edwin A M Gale
Clinical Medicine (London, England)|January 2, 2004
Between two cultures: the expert clinician and the pharmaceutical industryEdwin A M Gale
Diabetes|November 28, 2002
The rise of childhood type 1 diabetes in the 20th centuryEdwin A M Gale
The New England Journal of Medicine|May 31, 2002
Can we change the course of beta-cell destruction in type 1 diabetes?Edwin A M Gale
BMJ (Clinical Research Ed.)|March 22, 2008
Should we dump the metabolic syndrome? YesEdwin A M Gale
Pageof 34

Showing results (21-30 of 338) with videos related to

Sort By:
Pageof 34
Diabetologia|December 20, 2005
Troglitazone: the lesson that nobody learned?Edwin A M Gale
Lancet (London, England)|August 18, 2009
Insulin glargine and cancer: another side to the story?Edwin A M Gale
Diabetologia|July 22, 2008
Congenital rubella: citation virus or viral cause of type 1 diabetes?E A M Gale
Heart (British Cardiac Society)|January 15, 2013
Can NICE prevent diabetes?Edwin A M Gale
Diabetes Care|November 23, 2013
Response to comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125Edwin A M Gale
Diabetes|April 21, 2012
GLP-1-based therapies and the exocrine pancreas: more light, or just more heat?Edwin A M Gale
Clinical Medicine (London, England)|January 2, 2004
Between two cultures: the expert clinician and the pharmaceutical industryEdwin A M Gale
Diabetes|November 28, 2002
The rise of childhood type 1 diabetes in the 20th centuryEdwin A M Gale
The New England Journal of Medicine|May 31, 2002
Can we change the course of beta-cell destruction in type 1 diabetes?Edwin A M Gale
BMJ (Clinical Research Ed.)|March 22, 2008
Should we dump the metabolic syndrome? YesEdwin A M Gale
Pageof 34